one
hundr
year
magic
bullet
propos
paul
ehrlich
decad
establish
hybridoma
technolog
produc
monoclon
antibodi
mab
other
antibodi
final
becom
attract
therapeut
modal
high
potenc
antibodi
abil
gener
seemingli
unlimit
divers
specif
led
antibodybas
therapi
target
mani
differ
ill
diseas
major
therapeut
antibodi
current
avail
market
mous
origin
despit
proven
success
anim
immun
decad
gener
mab
therapeut
purpos
often
laborintens
timeconsum
process
requir
month
work
initi
immun
identif
specif
hybridoma
antibodi
although
approach
phage
display
human
memori
bcell
immort
clone
develop
deriv
fulli
human
mab
requir
anim
immun
method
shown
limit
success
due
challeng
associ
antibodi
nonimmun
origin
date
product
mab
immun
rodent
remain
highli
use
platform
gener
high
qualiti
therapeut
biolog
natur
vivo
recombin
affin
matur
antibodi
occur
humor
immun
respons
immun
anim
gener
effect
immun
respons
fundament
therapeut
antibodi
discoveri
also
crucial
vaccin
develop
combat
infecti
diseas
begin
host
immun
respons
elicit
foreign
antigenvaccin
immun
anim
immun
therapeut
antibodi
gener
requir
mechanismdriven
strategi
obtain
antibodi
demonstr
therapeut
mode
action
prior
hybridoma
fusion
andor
bcell
recoveri
effort
vaccin
develop
emphas
stimul
protect
immun
respons
host
immun
system
suffici
strength
qualiti
sustain
effici
long
term
protect
develop
optim
immun
respons
meet
either
goal
challeng
due
sophist
mechan
control
immun
respons
process
often
involv
multipl
critic
consider
select
candid
antigen
choic
adjuv
antigenvaccin
design
dosag
frequenc
applic
durat
immun
inject
protocol
etc
immun
respons
typic
monitor
measur
antibodi
titer
rel
concentr
antigenspecif
antibodi
blood
sampl
collect
immun
host
cours
immun
mani
commerci
kit
autom
system
avail
elisa
remain
wide
use
method
antibodi
titer
measur
due
simplic
low
cost
howev
convent
assay
partial
evalu
immun
respons
accur
reveal
data
bind
affin
specif
epitop
divers
polyclon
antibodi
import
effect
immun
campaign
lead
gener
high
qualiti
antibodi
respons
distinct
specif
increas
effici
therapeut
antibodi
gener
process
achiev
long
term
success
develop
altern
method
assess
qualiti
polyclon
antibodi
immun
sera
surfac
plasmon
reson
spr
hydrogen
deuterium
exchang
hdx
coupl
mass
spectrometri
propos
workflow
integr
sensit
method
antibodi
gener
platform
help
engin
immun
respons
provid
inform
effect
variou
immun
method
select
appropri
anim
antibodi
recoveri
access
inform
increas
probabl
success
recov
antibodi
meet
affin
andor
epitop
requir
report
describ
follow
method
develop
establish
detect
limit
techniqu
proofofconcept
studi
use
sera
immun
mice
creation
workflow
name
qualiti
antibodi
respons
qar
final
implement
workflow
therapeut
antibcel
activ
factor
baff
antibodi
gener
campaign
guid
select
optim
anim
donor
hybridoma
gener
demonstr
sensit
method
effect
differenti
antibodi
respons
among
variou
anim
therebi
contribut
success
recoveri
function
antibodi
beyond
use
therapeut
antibodi
discoveri
qar
workflow
also
appli
advanc
vaccin
develop
toward
goal
develop
robust
vaccin
enabl
analysi
mass
spectrometri
serum
igg
purifi
use
phynexu
autom
purif
system
tabl
ensur
purif
process
achiev
maxim
igg
recoveri
optim
igg
qualiti
sdspage
auc
use
use
naiv
serum
investig
number
elut
cycl
requir
full
retriev
bound
igg
sdspage
use
track
presenc
igg
sampl
consecut
elut
step
found
igg
could
longer
detect
beyond
elut
cycl
suggest
four
elut
step
suffici
data
shown
thu
use
four
elut
step
throughout
studi
nonreduc
sdspage
analysi
materi
purif
step
show
proplu
protein
ag
resin
effect
captur
igg
mous
sera
fig
although
remain
flowthrough
wash
step
solut
contain
multipl
band
elut
solut
show
singl
band
whose
size
correspond
typic
igg
molecular
mass
kda
result
confirm
use
reduc
sdspage
reveal
presenc
two
band
molecular
weight
correspond
heavi
light
chain
igg
band
four
sequenti
elut
cycl
gradual
decreas
signal
intens
expect
pool
eluat
whose
total
collect
volum
ml
concentr
puriti
homogen
evalu
use
auc
sediment
veloc
analysi
show
sampl
contain
monomer
igg
fig
concentrationdepend
bind
igg
human
demonstr
spr
use
sampl
contain
naiv
serum
variou
amount
ad
high
concentr
endogen
igg
serum
sampl
dilut
prior
protein
ag
captur
total
igg
includ
endogen
igg
captur
densiti
ru
expect
bind
respons
decreas
decreas
concentr
serum
fig
affin
determin
pm
satur
achiev
nm
human
differ
maxim
respons
level
nm
human
solut
inject
ident
iggcontain
surfac
data
shown
concentr
limit
antigenspecif
igg
detect
serum
determin
signal
ru
consid
background
nois
system
use
equat
describ
experiment
procedur
percentag
antigenspecif
igg
among
total
igg
calcul
reconstitut
sampl
shown
tabl
lower
limit
correspond
concentr
equival
total
igg
human
determin
iggbind
epitop
antigen
purifi
igg
subject
hdx
coupl
lcm
method
compar
deuterium
exchang
level
differ
region
antigen
presenc
absenc
antibodi
identifi
protect
igg
first
mock
experi
use
differ
concentr
human
absenc
igg
perform
determin
optim
concentr
protein
requir
ensur
full
sequenc
coverag
protein
result
reveal
concentr
yield
highest
sequenc
coverag
fig
thu
concentr
use
subsequ
experi
use
igg
sampl
epitop
map
experi
perform
incub
purifi
igg
human
describ
experiment
procedur
deuterium
uptak
compar
sampl
contain
human
absenc
presenc
hydrogen
mass
da
deuterium
mass
da
replac
hydrogen
protein
deuterium
induc
shift
mass
da
antibodi
bind
inhibit
deuterium
exchang
epitop
region
peptid
exhibit
shift
mass
associ
antibodi
epitop
shown
fig
larg
shift
mass
comparison
control
observ
peptid
encompass
residu
human
indic
region
protect
therefor
shift
mass
peptid
monitor
limit
detect
studi
fix
amount
human
incub
sampl
contain
titrat
concentr
purifi
endogen
igg
purifi
naiv
serum
use
neg
control
establish
background
signal
result
shown
fig
indic
observ
shift
mass
correspond
reduc
deuterium
incorpor
human
igg
concentrationdepend
expect
limit
detect
determin
indic
minimum
igg
concentr
requir
yield
detect
amount
deuterium
protect
total
nine
serum
sampl
mice
variou
strain
immun
human
evalu
use
spr
hdxlcm
method
serum
sampl
previous
character
binder
singl
point
elisa
analysi
shown
result
summari
tabl
analysi
show
serum
sampl
contain
differ
percentag
human
antibodi
exhibit
significantli
differ
averag
appar
affin
fig
among
nine
serum
sampl
four
sampl
e
show
human
bind
highest
test
concentr
nm
five
sampl
show
bind
appar
affin
rang
singledoubl
digit
picomolar
singl
digit
nanomolar
shown
spr
bind
data
differ
affin
influenc
variat
ka
kd
valu
although
serum
sampl
exhibit
faster
onrat
slower
offrat
henc
lower
kd
valu
higher
affin
interact
serum
serum
exhibit
higher
amount
human
igg
other
base
larger
experiment
rmax
valu
addit
observ
differ
antigenspecif
appar
affin
quantiti
polyclon
igg
among
nine
serum
sampl
found
bind
epitop
among
serum
sampl
also
differ
shown
fig
igg
serum
h
panel
c
protect
region
encompass
residu
deuterium
exchang
indic
serum
sampl
contain
igg
specif
region
similarli
igg
serum
fig
panel
also
show
protect
region
serum
h
rel
less
extens
mass
shift
like
due
weaker
affin
human
contrast
igg
serum
c
fig
panel
b
show
protect
region
exchang
observ
equival
control
contain
igg
panel
suggest
either
serum
sampl
contain
igg
target
region
level
igg
present
detect
limit
method
result
obtain
use
spr
hdx
lcm
consist
nonbind
show
bind
region
human
sampl
exhibit
epitop
protect
divers
rang
epitop
identifi
depict
fig
antibodi
respons
direct
toward
variou
helix
loop
region
human
protein
detect
amino
acid
human
shown
protect
indic
sequenc
elicit
antibodi
respons
serum
g
exhibit
divers
respons
serum
f
contain
antibodi
exclus
direct
c
terminu
protein
tabl
exhibit
least
divers
respons
given
success
method
differenti
antibodi
respons
among
differ
immun
anim
integr
qar
workflow
antibodi
gener
platform
help
guid
decisionmak
futur
immun
campaign
flowchart
shown
fig
indic
time
frame
qar
workflow
compon
approxim
week
immun
anim
antigen
antigenadjuv
mixtur
induct
effect
antibodi
respons
serum
sampl
evalu
elisa
determin
presenc
titer
antibodi
titer
result
posit
serum
sampl
directli
analyz
spr
determin
appar
bind
affin
quantifi
percentag
antigenspecif
igg
time
remain
volum
serum
sampl
subject
igg
purif
use
phynexu
autom
purif
system
spr
method
measur
six
serum
sampl
time
six
parallel
sampl
inject
base
multiplex
configur
protocol
typic
includ
multipl
bind
cycl
phynexu
mea
system
purifi
sampl
time
estim
run
time
h
multipl
mea
system
use
parallel
analyz
sampl
simultan
take
account
postpurif
sampl
prepar
time
enrich
bufferexchang
step
purifi
igg
sampl
readi
epitop
map
within
h
meanwhil
analysi
spr
data
provid
earli
inform
affin
quantiti
antibodi
sampl
reagent
prepar
hdx
lcm
experi
perform
overnight
use
autom
protocol
accur
control
deuterium
exchang
quench
reaction
time
sampl
deuterium
exchang
involv
sequenti
analysi
three
time
point
perform
complet
next
day
larg
amount
data
collect
ms
data
analysi
requir
halfday
data
process
use
two
inhousederiv
proprietari
softwar
applic
thu
comprehens
data
packag
gener
within
day
provid
use
feedback
guid
immun
approach
workflow
appli
point
immun
campaign
track
develop
antibodi
respons
qar
workflow
integr
baff
antibodi
gener
campaign
perform
evalu
similar
sera
analysi
antibaff
sera
analysi
tabl
reveal
differ
antibodi
qualiti
among
serum
sampl
addit
analyz
antibodi
bind
human
antigen
use
immun
also
analyz
antibodi
bind
cynomolgu
cyno
monkey
protein
use
spr
even
though
human
cynobaff
protein
share
sequenc
ident
serum
sampl
mice
exhibit
kd
valu
cynobaff
five
time
human
baff
indic
weaker
interact
analyz
bind
epitop
variou
antibodi
focus
antibodi
respons
region
human
baff
known
import
receptor
interact
inhous
analysi
indic
region
encompass
residu
import
function
data
shown
therefor
focus
attent
igg
found
target
region
among
serum
sampl
five
show
bind
respons
toward
least
one
priorit
epitop
region
although
four
sampl
exhibit
similar
doubl
digit
picomolar
better
affin
less
shift
bind
cynobaff
serum
sampl
mous
contain
highest
amount
human
baff
cynobaffspecif
igg
mous
subsequ
select
hybridoma
fusion
analysi
subclon
monoclon
antibodi
tabl
reveal
exhibit
low
picomolar
bind
human
baff
addit
blockad
receptor
bind
confirm
indic
select
mice
base
epitop
map
serum
igg
effect
strategi
increas
probabl
success
recov
criteriameet
function
antibodi
immun
campaign
explor
feasibl
appli
method
typic
use
later
antibodi
identif
process
name
spr
mass
spectrometri
character
antibodi
sera
immun
mice
profil
immun
respons
use
standard
elisa
method
measur
effect
immun
vaccin
wide
appli
report
use
spr
instead
sever
advantag
tradit
elisa
method
spr
labelfre
techniqu
perform
real
time
importantli
provid
highli
precis
measur
determin
associ
dissoci
rate
constant
achiev
elisa
applic
spr
analyz
complex
biolog
sampl
demonstr
sever
report
although
use
applic
still
rare
compar
immunoassay
anoth
advantag
use
spr
quantit
qualit
evalu
igg
serum
eas
includ
purif
step
igg
captur
protein
ag
onto
sensor
surfac
protein
ag
affin
mous
igg
isotyp
therefor
use
reagent
ensur
antigen
affin
antibodi
mous
serum
effect
evalu
result
bind
signal
highli
specif
igg
furthermor
amount
antigenspecif
igg
present
serum
quantifi
calcul
rmax
valu
accord
result
use
reconstitut
sampl
detect
limit
high
affin
low
picomolar
bind
antibodi
serum
use
spr
epitop
map
elucid
specif
antibodi
respons
divers
crucial
obtain
antibodi
desir
mechan
action
tradit
antigenantibodi
contact
surfac
determin
method
high
resolut
xray
crystallographi
sitedirect
mutagenesi
howev
method
applic
purpos
sampl
contain
antibodi
mixtur
addit
amount
materi
avail
analysi
time
frame
acquir
epitop
inform
limit
search
suitabl
techniqu
initi
explor
peptid
microarray
librari
linear
synthet
peptid
use
screen
iggbind
epitop
sampl
contain
mab
known
bind
epitop
well
sera
naiv
anim
anim
immun
human
test
use
method
howev
unabl
identifi
specif
epitop
either
mab
antibodi
present
sera
data
shown
regardless
find
provid
two
import
insight
first
learn
bind
epitop
control
mab
conform
rather
linear
second
learn
presenc
serum
protein
probabl
interf
method
therefor
consid
altern
techniqu
could
facilit
identif
nativ
protein
conform
epitop
solut
high
resolut
ultim
select
hdx
coupl
lcm
due
low
materi
consumpt
rel
high
throughput
via
robot
autom
high
sensit
combin
hydrogen
deuterium
exchang
mass
spectrometri
proven
increasingli
power
character
protein
conform
structur
dynam
proteinprotein
interact
even
though
hdx
establish
method
success
appli
inhous
map
epitop
purifi
mab
high
concentr
sever
challeng
exist
evalu
igg
serum
therefor
addit
method
develop
requir
improv
feasibl
approach
one
major
challeng
matrix
effect
serum
could
produc
signific
interfer
inject
directli
instrument
address
issu
develop
small
scale
affin
purif
protocol
use
phynexu
system
purifi
igg
serum
use
protein
ag
column
platform
select
avail
system
autom
rel
high
throughput
enabl
purif
serum
sampl
simultan
purif
scheme
optim
achiev
maxim
igg
recoveri
puriti
result
show
highli
pure
igg
could
obtain
serum
sampl
second
challeng
involv
sensit
method
detect
antibodi
epitop
mixtur
igg
present
differ
concentr
improv
sensit
sever
modif
made
sampl
prepar
includ
use
concentr
increas
igg
concentr
ph
adjust
via
buffer
exchang
optim
deuterium
exchang
effici
incorpor
addit
sampleprocess
step
import
determin
igg
recov
suffici
concentr
signal
detect
experi
high
affin
mab
known
bind
epitop
evalu
differ
concentr
show
sensit
method
ng
antigenspecif
igg
per
serum
high
sensit
facilit
detect
less
abund
igg
exhibit
uniqu
epitop
maxim
divers
antibodi
recov
establish
highli
sensit
spr
hdx
lcm
method
detect
antigenspecif
antibodi
serum
test
perform
use
sera
immun
mice
nine
serum
sampl
collect
variou
strain
mice
immun
human
use
differ
protocol
analyz
method
proofofconcept
studi
sampl
previous
classifi
binder
singl
point
elisa
analysi
anticip
result
analys
allow
us
differenti
antibodi
respons
among
immun
mice
respect
appar
antigen
affin
amount
antigenspecif
activ
epitop
divers
inhibit
function
develop
high
affin
antibodi
target
differ
epitop
protein
result
either
disrupt
receptor
bind
disrupt
bind
requir
analysi
nine
differ
mous
sera
reveal
import
bind
affin
epitop
inform
allow
us
differenti
qualiti
antibodi
respons
although
five
serum
sampl
found
contain
antibodi
bound
surfac
interact
receptor
epitop
two
sera
g
contain
addit
antibodi
bound
surfac
interact
epitop
epitop
g
maxim
recoveri
function
antibodi
serum
g
therefor
would
best
choic
subsequ
antibodi
gener
contain
high
affin
antibodi
could
target
mechan
action
although
hybridoma
fusion
perform
assess
recoveri
function
monoclon
antibodi
target
human
perform
track
assess
antibodi
gener
baff
program
see
develop
qar
workflow
top
prioriti
ensur
time
frame
gener
data
packag
short
enough
enabl
time
decisionmak
reflect
select
method
throughput
essenti
consider
accord
assess
complet
data
packag
compil
within
busi
day
due
larg
part
autom
platform
method
multiplex
spr
array
tip
columnbas
walk
away
serum
purif
liquidhandl
hdx
reaction
control
minim
need
extens
manual
work
furthermor
implement
inhous
ms
softwar
program
autom
hdx
data
analysi
beyond
scope
paper
entir
workflow
process
effici
execut
support
addit
iter
necessari
shown
tabl
use
qar
workflow
guid
develop
therapeut
antibaff
antibodi
demonstr
data
packag
contribut
success
retriev
function
antibaff
antibodi
time
manner
focus
identif
immun
anim
produc
high
affin
antibodi
target
well
defin
epitop
use
hybridoma
fusion
comprehens
data
packag
gener
confirm
method
provid
clear
differenti
among
antibodi
respons
variou
anim
find
method
consist
provid
indepth
time
inform
direct
develop
high
qualiti
antibodi
suggest
widespread
util
guid
therapeut
antibodi
product
futur
summari
demonstr
combin
sensit
method
integr
antibodi
gener
platform
help
identifi
anim
host
exhibit
high
affin
antibodi
respons
maxim
epitop
divers
combin
spr
hdx
lcm
enabl
comprehens
quantit
qualit
evalu
antibodi
present
serum
sampl
spr
analysi
provid
antibodi
affin
inform
antigenspecif
antibodi
quantif
ms
analysi
provid
inform
structur
interact
serum
antibodi
antigen
thu
complementari
method
reveal
uniqu
inform
obtain
use
convent
method
propos
workflow
process
also
execut
speed
biopharmaceut
industri
demand
discov
novel
epitop
new
therapeut
mode
action
addit
qar
workflow
use
guid
develop
robust
vaccin
describ
method
use
monitor
develop
novel
immunogen
vaccin
prepar
deliveri
system
earli
stage
develop
help
predict
efficaci
safeti
knowledg
first
report
demonstr
describ
method
implement
produc
indepth
inform
distinguish
antibodi
respons
guid
product
therapeut
antibodi
intend
follow
addit
studi
demonstr
util
workflow
futur
therapeut
antibodi
vaccin
discoveri
program
recombin
human
deriv
escherichia
coli
purchas
r
system
minneapoli
mn
mous
mab
clone
deriv
previou
campaign
produc
transient
express
cho
cell
purifi
use
mabselect
surebas
affin
chromatographi
ge
healthcar
purifi
mab
formul
mm
sodium
acet
ph
buffer
determin
detect
limit
method
eight
naiv
mous
serum
sampl
contain
differ
antibodi
concentr
rang
prepar
serial
dilut
recombin
human
baff
tag
receptor
tacihumanfc
chimer
protein
purchas
r
system
antibaff
mab
supernat
produc
use
hybridoma
gener
use
spleen
cell
mous
follow
clone
subclon
use
limit
dilut
antibodi
isotyp
determin
use
mous
isostriptm
monoclon
antibodi
isotyp
kit
santa
cruz
biotechnolog
dalla
tx
naiv
mous
pool
serum
filter
mix
strain
purchas
bioreclamationivt
westburi
ny
serum
sampl
nine
mice
differ
strain
balbc
swiss
webster
immun
human
store
use
proofofconcept
analysi
mice
variou
mhc
haplotyp
immun
twice
human
baff
serum
sampl
obtain
week
second
immun
store
day
mice
boost
baff
spleen
harvest
hybridoma
fusion
use
standard
techniqu
hybridoma
screen
carri
luminex
beadbas
assay
use
human
baff
posit
candid
clone
limit
dilut
measur
valu
mabbaff
interact
magnet
luminex
bead
coat
human
baff
incub
dilut
seri
mab
h
mabbaffbound
bead
wash
incub
biotinyl
antimous
fcspecif
antibodi
h
incub
streptavidinphycoerythrin
anoth
min
signal
detect
antibaff
hybridoma
subclon
character
abil
block
bafftaci
interact
assay
baffcoat
bead
first
incub
sampl
dilut
mab
h
tacihuman
fc
ngml
ad
mixtur
incub
h
follow
addit
biotinyl
antihuman
fcspecif
antibodi
h
taci
bind
detect
incub
streptavidinphycoerythrin
mous
antibodi
purifi
fulli
autom
phynexu
mea
purif
system
phynexu
inc
use
phytip
column
pack
proplu
resin
part
dispos
pipett
tip
proplu
resin
protein
aderiv
ligand
attribut
protein
g
bind
specif
mous
isotyp
mous
serum
sampl
dilut
pb
transfer
individu
well
well
plate
addit
sampl
plate
two
reagent
plate
contain
wash
elut
neutral
buffer
purif
step
also
prepar
although
sampl
plate
place
posit
mea
instrument
platform
kept
room
temperatur
reagent
plate
place
posit
top
chiller
maintain
temperatur
number
phytip
column
correspond
number
sampl
transfer
row
empti
pipett
tip
box
locat
posit
similarli
number
standard
rainin
lt
pipett
tip
transfer
row
box
use
last
neutral
step
transfer
basic
solut
eluent
prepack
phytip
column
reagent
plate
load
onto
mea
instrument
platform
mous
antibodi
isol
use
method
program
phynexu
mea
softwar
version
consist
follow
step
prewash
equilibr
resin
pb
captur
igg
dilut
mous
serum
sampl
proplu
affin
resin
wash
pb
pb
plu
nacl
remov
serum
protein
elut
bound
igg
resin
mm
sodium
acet
ph
three
time
follow
one
elut
mm
sodium
acet
ph
ensur
full
remov
remain
bound
igg
resin
neutral
use
volum
mm
sodium
acet
ph
bring
final
formul
mm
sodium
acet
ph
detail
purif
step
respect
oper
configur
includ
protocol
list
tabl
tabl
one
cycl
repres
one
intak
one
expuls
solut
proplu
resin
speed
defin
flow
rate
flow
rate
captur
maintain
mlmin
ensur
suffici
contact
time
serum
sampl
resin
delay
delay
time
intak
expuls
step
allow
contact
solut
posit
axi
distanc
tip
bottom
plate
valu
preset
use
set
recommend
manufactur
protein
detect
sampl
analyz
reduc
nonreduc
condit
use
nupag
bistri
gel
nupag
mop
sd
run
buffer
novex
xcell
surelock
minicel
system
invitrogen
v
min
gel
stain
use
instant
blue
coomassiebas
solut
expedeon
san
diego
imag
gel
obtain
use
canoscan
scanner
qualiti
purifi
igg
evalu
sediment
veloc
experi
use
absorb
optic
beckman
xli
analyt
ultracentrifug
beckman
coulter
inc
concentr
igg
elut
pool
dilut
mm
sodium
acet
ph
mgml
load
sampl
chamber
wherea
buffer
load
refer
chamber
auc
cell
assembl
standard
doublesector
centerpiec
quartz
window
experi
conduct
use
fourhol
rotor
spin
rpm
sediment
process
monitor
collect
absorb
data
nm
use
xli
oper
softwar
collect
data
analyz
use
continu
c
distribut
model
sedfit
softwar
version
provid
distribut
sediment
coeffici
valu
obtain
c
distribut
sodium
acet
buffer
convert
valu
sednterp
version
use
measur
densiti
viscos
buffer
biosensor
experi
perform
use
proteon
instrument
biorad
precondit
glm
chip
dock
machin
sd
naoh
nacl
across
six
channel
direct
protein
ag
aminecoupl
onto
chip
surfac
use
standard
coupl
protocol
follow
step
six
individu
flow
channel
activ
parallel
inject
freshli
mix
solut
n
nhydroxysuccinimid
protein
ag
prepar
sodium
acet
ph
immobil
activ
channel
excess
reactiv
ester
deactiv
ethanolamin
step
perform
flow
rate
min
protein
ag
high
surfac
densiti
respons
unit
ru
coupl
onto
chip
surfac
captur
serum
igg
character
bind
affin
small
volum
serum
sampl
dilut
pbstweenedta
run
buffer
six
dilut
sampl
inject
simultan
six
avail
vertic
channel
flow
rate
igg
captur
protein
ag
captur
time
monitor
achiev
high
antibodi
surfac
densiti
ru
high
abund
mous
igg
serum
sampl
captur
time
suffici
reach
target
densiti
level
follow
blank
buffer
inject
six
individu
igg
surfac
five
titrat
concentr
antigen
dilut
simultan
inject
horizont
direct
bind
interact
monitor
associ
period
dissoci
period
use
high
flow
rate
last
channel
inject
pbstweenedta
refer
subtract
surfac
regener
two
puls
glycin
ph
horizont
vertic
direct
allow
captur
differ
serum
igg
kinet
bind
measur
collect
sensorgram
data
process
refer
subtract
use
interspot
addit
doublereferenc
inlin
buffer
blank
integr
proteon
manag
softwar
version
use
fit
data
langmuir
model
describ
bind
stoichiometri
ka
associ
rate
constant
antibodyantigen
bind
kd
dissoci
rate
constant
antibodytarget
complex
kd
equilibrium
dissoci
constant
defin
kdka
ratio
addit
determin
appar
bind
affin
fit
bind
curv
experiment
bind
capac
surfac
rmax
also
deriv
comparison
experiment
rmax
theoret
rmax
provid
percentag
igg
specif
antigen
among
total
igg
present
serum
equat
obtain
theoret
rmax
equat
use
mwanalyt
molecular
weight
antigen
mwligand
molecular
weight
igg
captur
sensor
surfac
n
bind
stoichiometri
reaction
immobil
ligand
level
level
captur
serum
igg
includ
endogen
igg
antigenspecif
igg
prepar
sampl
epitop
map
analysi
mass
spectrometri
dilut
sampl
ml
purifi
mous
igg
concentr
use
molecular
weight
cutoff
centrifug
filter
devic
millipor
billerica
load
filter
devic
spun
swing
bucket
rotor
g
min
concentr
collect
subsequ
bufferexchang
pb
use
zeba
spin
desalt
column
thermofish
scientif
maintain
physiolog
ph
bind
interact
ensur
consist
deuterium
exchang
determin
minim
amount
antigen
need
full
sequenc
coverag
differ
amount
antigen
aliquot
dilut
pb
total
volum
analysi
lowest
amount
antigen
yield
highest
sequenc
coverag
select
amount
directli
ad
purifi
antibodi
sampl
yield
total
volum
use
hdx
paltm
robot
system
leap
technolog
inc
sampl
contain
igg
incub
human
ad
buffer
reaction
subsequ
quench
consist
time
temperatur
use
autom
sampl
run
list
two
separ
sampl
compart
use
experi
one
compart
kept
label
deuterium
exchang
maintain
reaction
quench
sampl
prepar
transfer
chromacol
screen
top
vial
thermofish
scientif
store
individu
posit
within
sampl
compart
work
list
written
use
hdxdirector
version
follow
step
dilut
mix
sampl
deuterium
exchang
buffer
mm
ph
incub
mixtur
variou
time
period
exchang
reaction
took
place
end
incub
period
mixtur
transfer
vial
contain
quench
solut
guanidin
hydrochlorid
tri
phosphin
hydrochlorid
mix
thoroughli
final
quench
reaction
mixtur
inject
onto
immobil
pepsin
column
life
technolog
inc
min
protein
digest
subsequ
desalt
acquiti
uplc
beh
vanguard
precolumn
water
technolog
addit
min
prior
inject
beh
column
water
technolog
lc
revers
phase
separ
digest
peptid
inject
onto
column
insid
columnvalv
temperaturecontrol
compart
gradient
solvent
system
consist
precool
mobil
phase
formic
acid
hplc
water
acetonitril
mobil
phase
b
formic
acid
hplc
water
acetonitril
use
column
first
equilibr
b
oncolumn
pepsin
digest
gradient
move
b
peptid
wash
vanguard
precolumn
chromatograph
separ
perform
flow
rate
appli
gradient
mobil
phase
b
min
min
min
final
min
chromatograph
separ
sampl
enter
orbitrap
fusiontm
mass
spectromet
oper
posit
electrospray
ioniz
mode
employ
method
includ
activ
type
collisioninduc
dissoci
electron
transfer
dissoci
identifi
control
peptid
use
resolut
minimum
signal
isol
width
normal
collis
energi
v
slen
radiofrequ
rf
level
set
peptid
identif
data
collect
profil
mode
full
ms
scan
centroid
mode
collisioninduc
dissoci
electron
transfer
dissoci
msm
scan
data
collect
mass
rang
da
deuter
sampl
msm
data
collect
collect
raw
lcmsm
fragment
data
pepsin
digest
analyz
use
variou
softwar
tool
peptid
identif
fragment
data
control
sampl
antigen
absenc
igg
analyz
use
proteom
discov
thermo
scientif
pmi
byonic
protein
metric
inc
compar
given
sequenc
gener
list
peptid
retent
time
raw
lcmsm
data
file
preprocess
convert
ascii
format
use
proprietari
inhous
softwar
identifi
peptid
match
summar
epitop
determin
calcul
differ
averag
mass
shift
induc
protect
region
deuterium
label
wrote
first
draft
manuscript
l
f
develop
variou
method
perform
experi
analyz
data
l
evalu
peptid
microarray
facilit
implement
method
k
provid
hdx
lcm
experiment
support
softwar
data
analysi
r
k
provid
technic
guidanc
oversight
throughout
entir
process
conceptu
process
provid
oversight
author
discuss
result
implic
comment
manuscript
stage
